2014 In Vivo Magnetic Resonance Gordon Research Conference

描述（由申请人提供）：本申请申请支持第八届戈登体内磁共振研究会议。本次会议将使来自物理科学、生命科学、工程和临床科学的工作者沉浸在一个激烈的多学科环境中，鼓励思想和知识的整合，加速人类和动物磁共振成像和光谱学技术的发展，并确保其在生物医学科学和改善临床护理方面的利用，最终目的是改善人类健康。第八届体内MRI戈登会议将于2014年7月27日至8月1日在新罕布什尔州安多弗的Proctor学院举行。主席是英国诺丁汉大学物理与天文学院磁共振教授Penny A Gowland博士，副主席是德国弗莱堡大学医院放射科医学物理学教授Jurgen K Hennig博士。2012年举行的第七届In Vivo MR GRC非常成功（90%的与会者对会议的所有评估领域的评价“高于平均水平”）。磁场强度和仪器的进步，以及一系列新的成像技术，数据分析方法和造影剂继续为快速增长创造丰富的环境。因此，将这一领域的领军人物和未来的研究者聚集在一起讨论这一重要领域的下一个方向是及时的。会议将包括科学会议，由两名或三名发言者和一名讨论负责人（一般包括至少一名青年科学家）讨论将对这一非凡领域的发展产生重大影响的新出现的技术、生物和健康相关问题。还将有海报会议，大多数与会者将提交海报，并进行讨论，以促进与会者之间的密切互动。按照传统标准，GRC会议规模较小（150-200人），并邀请/招募参与者，以确保代表学术机构和政府机构的不同群体的初级和高级研究人员以及来自公司研究项目的个人参加会议。学生和博士后将被强烈鼓励参加，并提供学生津贴来抵消一些出席费用；美国国立卫生研究院请求的支持将用于帮助提供津贴。将特别注意鼓励妇女、少数民族和残疾人参加。将邀请工业界参加和赞助这次会议，因为工业利用磁共振的新发展对于确保其迅速翻译和传播以及经济发展至关重要。该领域没有其他科学论坛能在如此亲密和非正式的环境中提供如此广泛和深入的课程，包括来自不同学科的国际领先专家和新生。因此，没有任何其他会议能够产生如此广泛的富有成效的新互动，这些互动是开发磁共振新思想以加强生物医学研究和改善医疗保健所必需的。

DESCRIPTION (provided by applicant): This application requests support for the eighth Gordon Research Conference on In Vivo Magnetic Resonance. This meeting will immerse workers from the physical sciences, life sciences, engineering and clinical sciences in an intense multidisciplinary environment, to encourage the integration of ideas and knowledge, to accelerate the development Magnetic Resonance Imaging and Spectroscopy techniques for humans and animals and to ensure their exploitation in biomedical science and improved clinical care, with the ultimate aim of improving human health. The eighth In Vivo MRI Gordon Conference will be held July 27 to August 1, 2014, at Proctor Academy, Andover, NH. The Chair is Penny A Gowland, PhD, Professor in Magnetic Resonance in the School of Physics and Astronomy, University of Nottingham, UK, and the vice-Chair is Jurgen K Hennig, PhD, Professor of Medical Physics in the Department of Radiology, University Hospital Freiburg, Germany. The seventh In Vivo MR GRC, held in 2012, was extremely successful (90% attendees evaluated the meeting "above average" on all evaluation areas). Advances in magnet field strength and instrumentation, and an array of new imaging techniques, data analysis methods and contrast agents continue to create a rich environment for rapid growth. It is thus timely to gather together the leading individuals and future investigators in this area to address the next directions for this important field. The Conference will include scientific sessions, wit two or three speakers and a discussion leader (generally including at least one young scientist), addressing emerging technological, biological and health related issues that will significantly impact on the growth of this remarkable field. There will also be poster sessions, with most participants expected to present a poster, and discussions designed to facilitate close interaction between the participants. GRC meetings are small by conventional standards (150-200 participants) with participants invited/recruited to ensure attendance by a diverse group of junior and senior investigators representing academic and government institutions and individuals from corporate research programs. Students and postdoctoral fellows will be strongly encouraged to attend, with student stipends being offered to offset some of the costs of attendance; the support being requested from the NIH will be used to help provide stipends. Particular attention will be paid to encouraging attendance by women, minorities, and the disabled. Industry will be invited to attend and sponsor the meeting since industrial exploitation of new developments in magnetic resonance is essential to ensure their rapid translation and dissemination and for economic development. No other scientific forum in this field provides the same breadth and depth of program in such an intimate and informal setting, involving both internationally leading experts and new students from a diverse range of disciplines. Thus no other meeting produces such range of fruitful new interactions necessary to exploit new ideas in Magnetic Resonance for enhanced biomedical research and improved health care.